Report Detail
Global Genital Herpes Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4521983 |
- 14 March, 2023 |
- Global |
- 93 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Genital Herpes Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Genital Herpes Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Genital Herpes Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Genital Herpes Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Genital Herpes Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Genital Herpes Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genital Herpes Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genital Herpes Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, BioNTech, Beike Bio and Changsheng Biotechnology. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Genital Herpes Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Zoster Vaccine Live
Recombinant Zoster Vaccine
Market segment by Application
Male
Female
Major players covered
GSK
Merck
BioNTech
Beike Bio
Changsheng Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Genital Herpes Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Genital Herpes Vaccine, with price, sales, revenue and global market share of Genital Herpes Vaccine from 2018 to 2023.
Chapter 3, the Genital Herpes Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genital Herpes Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Genital Herpes Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Genital Herpes Vaccine.
Chapter 14 and 15, to describe Genital Herpes Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Genital Herpes Vaccine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Genital Herpes Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Zoster Vaccine Live
- 1.3.3 Recombinant Zoster Vaccine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Genital Herpes Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Male
- 1.4.3 Female
- 1.5 Global Genital Herpes Vaccine Market Size & Forecast
- 1.5.1 Global Genital Herpes Vaccine Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Genital Herpes Vaccine Sales Quantity (2018-2029)
- 1.5.3 Global Genital Herpes Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Genital Herpes Vaccine Product and Services
- 2.1.4 GSK Genital Herpes Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 GSK Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Genital Herpes Vaccine Product and Services
- 2.2.4 Merck Genital Herpes Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 BioNTech
- 2.3.1 BioNTech Details
- 2.3.2 BioNTech Major Business
- 2.3.3 BioNTech Genital Herpes Vaccine Product and Services
- 2.3.4 BioNTech Genital Herpes Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 BioNTech Recent Developments/Updates
- 2.4 Beike Bio
- 2.4.1 Beike Bio Details
- 2.4.2 Beike Bio Major Business
- 2.4.3 Beike Bio Genital Herpes Vaccine Product and Services
- 2.4.4 Beike Bio Genital Herpes Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Beike Bio Recent Developments/Updates
- 2.5 Changsheng Biotechnology
- 2.5.1 Changsheng Biotechnology Details
- 2.5.2 Changsheng Biotechnology Major Business
- 2.5.3 Changsheng Biotechnology Genital Herpes Vaccine Product and Services
- 2.5.4 Changsheng Biotechnology Genital Herpes Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Changsheng Biotechnology Recent Developments/Updates
3 Competitive Environment: Genital Herpes Vaccine by Manufacturer
- 3.1 Global Genital Herpes Vaccine Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Genital Herpes Vaccine Revenue by Manufacturer (2018-2023)
- 3.3 Global Genital Herpes Vaccine Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Genital Herpes Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Genital Herpes Vaccine Manufacturer Market Share in 2022
- 3.4.2 Top 6 Genital Herpes Vaccine Manufacturer Market Share in 2022
- 3.5 Genital Herpes Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Genital Herpes Vaccine Market: Region Footprint
- 3.5.2 Genital Herpes Vaccine Market: Company Product Type Footprint
- 3.5.3 Genital Herpes Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Genital Herpes Vaccine Market Size by Region
- 4.1.1 Global Genital Herpes Vaccine Sales Quantity by Region (2018-2029)
- 4.1.2 Global Genital Herpes Vaccine Consumption Value by Region (2018-2029)
- 4.1.3 Global Genital Herpes Vaccine Average Price by Region (2018-2029)
- 4.2 North America Genital Herpes Vaccine Consumption Value (2018-2029)
- 4.3 Europe Genital Herpes Vaccine Consumption Value (2018-2029)
- 4.4 Asia-Pacific Genital Herpes Vaccine Consumption Value (2018-2029)
- 4.5 South America Genital Herpes Vaccine Consumption Value (2018-2029)
- 4.6 Middle East and Africa Genital Herpes Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 5.2 Global Genital Herpes Vaccine Consumption Value by Type (2018-2029)
- 5.3 Global Genital Herpes Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 6.2 Global Genital Herpes Vaccine Consumption Value by Application (2018-2029)
- 6.3 Global Genital Herpes Vaccine Average Price by Application (2018-2029)
7 North America
- 7.1 North America Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 7.2 North America Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 7.3 North America Genital Herpes Vaccine Market Size by Country
- 7.3.1 North America Genital Herpes Vaccine Sales Quantity by Country (2018-2029)
- 7.3.2 North America Genital Herpes Vaccine Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 8.2 Europe Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 8.3 Europe Genital Herpes Vaccine Market Size by Country
- 8.3.1 Europe Genital Herpes Vaccine Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Genital Herpes Vaccine Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Genital Herpes Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Genital Herpes Vaccine Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Genital Herpes Vaccine Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 10.2 South America Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 10.3 South America Genital Herpes Vaccine Market Size by Country
- 10.3.1 South America Genital Herpes Vaccine Sales Quantity by Country (2018-2029)
- 10.3.2 South America Genital Herpes Vaccine Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Genital Herpes Vaccine Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Genital Herpes Vaccine Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Genital Herpes Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Genital Herpes Vaccine Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Genital Herpes Vaccine Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Genital Herpes Vaccine Market Drivers
- 12.2 Genital Herpes Vaccine Market Restraints
- 12.3 Genital Herpes Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Genital Herpes Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Genital Herpes Vaccine
- 13.3 Genital Herpes Vaccine Production Process
- 13.4 Genital Herpes Vaccine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Genital Herpes Vaccine Typical Distributors
- 14.3 Genital Herpes Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Genital Herpes Vaccine. Industry analysis & Market Report on Genital Herpes Vaccine is a syndicated market report, published as Global Genital Herpes Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Genital Herpes Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
